The Glaucoma Foundation Annual Think Tank convenes experts, from diverse fields, and from across the country and around the world, to share their insights and chart the course for future research that will lead to better treatments on our way to a cure.

SESSION 5: NonIOP Factors of Importance in Glaucoma, Moderator, Jeffrey M. Liebmann, MD
0:00 Introduction Jeffrey M. Liebmann, MD
0:01:20 Diet and Glaucoma – Jae Hee Kang, ScD
0:36:00 Hypertension, Antihypertensive Drugs and Glaucoma – Alon Harris, PhD
01:11:20 The Impact of Glaucoma on Activities of Daily Living – Pradeep Ramulu, MD
01:37:37 Audience Questions

Jeffrey M. Liebmann, MD is the Shirlee and Bernard Brown Professor, ViceChair, and Director of the Glaucoma Division of the Department Ophthalmology at Columbia University Medical Center. He is a fellow of the American Academy of Ophthalmology, Association for Research in Vision and Ophthalmology and American College of Surgeons. Dr. Liebmann serves as a member of the board of governors of the World Glaucoma Association, board of directors of The Glaucoma Foundation, and secretarytreasurer of the New York Glaucoma Society. Dr. Liebmann is a past president of the World Glaucoma Association, American Glaucoma Society, and the New York Society for Clinical Ophthalmology, an emeritus editorin chief of Journal of Glaucoma, and a cofounder of the New York Glaucoma Research Institute, the American Glaucoma Society Foundation, and ASCRS Glaucoma Day.

Jae Hee Kang, ScD Using large, complex longitudinal data from large prospective cohort studies at Harvard, Dr. Kang has led and collaborated on research projects to evaluate a wide range of risk factors (nutritional, genetic and pharmacologic) in relation to a variety of outcomes to inform primary prevention strategies for glaucoma.

Alon Harris, PhD is an internationally recognized expert and leader in the field of ocular blood flow and glaucoma with more than seven million dollars in research funding from such prestigious institutions as the National Institutes of Health, and the National Eye Institute. He has served as principal investigator on dozens of industrysponsored clinical trials. An internationally recognized entrepreneur in the field of ophthalmology, he has extensive experience in navigating, fundraising, and bridging the transition from academic discovery to marketplace solutions.

Pradeep Ramulu, MD's research focuses primarily on how glaucoma affects the individual. Specifically, he has studied the types of difficulties that glaucoma patients experience with regards to reading, walking, falling, driving, and traveling outside the home. His longterm interests are to understand when and how glaucoma should be treated based on a more complete understanding of how patients are affected by their disease. Additionally, his work is geared toward developing rehabilitative strategies for individuals with severe vision loss from glaucoma, and in developing recommendations to increase the safety and quality of life of all individuals with glaucoma.

STAY IN THE LOOP:
Visit our website https://glaucomafoundation.org/
Follow us on Instagram   / theglaucomafoundation  
Follow us on Facebook   / the.glaucoma.foundation  
Follow us on LinkedIn   / theglaucomafoundation  
Follow us on TikTok   / the_glaucoma_foundation